Does DABIGATRAN ETEXILATE Cause Hepatic function abnormal? 40 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Hepatic function abnormal have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.1% of all adverse event reports for DABIGATRAN ETEXILATE.
40
Reports of Hepatic function abnormal with DABIGATRAN ETEXILATE
0.1%
of all DABIGATRAN ETEXILATE reports
6
Deaths
22
Hospitalizations
How Dangerous Is Hepatic function abnormal From DABIGATRAN ETEXILATE?
Of the 40 reports, 6 (15.0%) resulted in death, 22 (55.0%) required hospitalization, and 12 (30.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Hepatic function abnormal Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB